165 related articles for article (PubMed ID: 37671793)
21. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.
Ferry T; Kolenda C; Briot T; Souche A; Lustig S; Josse J; Batailler C; Pirot F; Medina M; Leboucher G; Laurent F; On Behalf Of The Lyon Bji Study Group ; On Behalf Of The PHAGEinLYON Study Group
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960683
[TBL] [Abstract][Full Text] [Related]
22. Targeted Therapy of Severe Infections Caused by
Gatti M; Viaggi B; Rossolini GM; Pea F; Viale P
Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838359
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica.
Crowe M; Ashford K; Ispahani P
J Med Microbiol; 1996 Oct; 45(4):302-9. PubMed ID: 8849705
[TBL] [Abstract][Full Text] [Related]
24. Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review.
Telles JP; Cieslinski J; Tuon FF
Braz J Infect Dis; 2019; 23(3):191-196. PubMed ID: 31207214
[TBL] [Abstract][Full Text] [Related]
25. Current concepts in the management of infections in bones and joints.
Dickie AS
Drugs; 1986 Nov; 32(5):458-75. PubMed ID: 3792229
[TBL] [Abstract][Full Text] [Related]
26. Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children.
Jagodzinski NA; Kanwar R; Graham K; Bache CE
J Pediatr Orthop; 2009; 29(5):518-25. PubMed ID: 19568027
[TBL] [Abstract][Full Text] [Related]
27. A pilot study of oral fleroxacin given once daily in patients with bone and joint infections.
Putz PA
Am J Med; 1993 Mar; 94(3A):177S-181S. PubMed ID: 8452177
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?
Klein S; Nurjadi D; Eigenbrod T; Bode KA
Int J Antimicrob Agents; 2016 Feb; 47(2):155-7. PubMed ID: 26774158
[TBL] [Abstract][Full Text] [Related]
29. Osteomyelitis and septic arthritis in children.
De Boeck H
Acta Orthop Belg; 2005 Oct; 71(5):505-15. PubMed ID: 16305073
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and outcomes in children with bone and joint infections of the ankle or foot.
Nadau E; Joseph C; Haraux E; Deroussen F; Gouron R; Klein C
Arch Pediatr; 2020 Nov; 27(8):464-468. PubMed ID: 33011034
[TBL] [Abstract][Full Text] [Related]
31. Osteomyelitis: an update for hospitalists.
Howell WR; Goulston C
Hosp Pract (1995); 2011 Feb; 39(1):153-60. PubMed ID: 21441771
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients.
Pouderoux C; Becker A; Goutelle S; Lustig S; Triffault-Fillit C; Daoud F; Fessy MH; Cohen S; Laurent F; Chidiac C; Valour F; Ferry T;
J Antimicrob Chemother; 2019 Jul; 74(7):2060-2064. PubMed ID: 31220276
[TBL] [Abstract][Full Text] [Related]
33. Emergency department management of pediatric septic arthritis and osteomyelitis.
Gill P; Sanders JE
Pediatr Emerg Med Pract; 2019 Dec; 16(12):1-24. PubMed ID: 31765551
[TBL] [Abstract][Full Text] [Related]
34. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections.
Stengel D; Bauwens K; Sehouli J; Ekkernkamp A; Porzsolt F
Lancet Infect Dis; 2001 Oct; 1(3):175-88. PubMed ID: 11871494
[TBL] [Abstract][Full Text] [Related]
35. [Osteoarticular infections: clinical studies].
Grimprel E; Lorrot M; Haas H; Pinquier D; Parez N; Ferroni A; Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S68-73. PubMed ID: 19000858
[TBL] [Abstract][Full Text] [Related]
36. Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review.
Tsegka KG; Voulgaris GL; Kyriakidou M; Kapaskelis A; Falagas ME
Expert Rev Anti Infect Ther; 2022 Jan; 20(1):33-43. PubMed ID: 34030567
[TBL] [Abstract][Full Text] [Related]
37. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.
LeFrock JL; Ristuccia AM; Ristuccia PA; Quenzer RW; Haggerty PG; Allen JE; Lettau LA; Schwartz R; Appleby D
Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644
[TBL] [Abstract][Full Text] [Related]
38. Bone and Joint Infections in Older Adults.
Mears SC; Edwards PK
Clin Geriatr Med; 2016 Aug; 32(3):555-70. PubMed ID: 27394023
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy.
Marks M; Bell LCK; Jones I; Rampling T; Kranzer K; Morris-Jones S; Logan S; Pollara G
Clin Infect Dis; 2020 Jun; 71(1):207-210. PubMed ID: 31603189
[TBL] [Abstract][Full Text] [Related]
40. Microbiology and management of joint and bone infections due to anaerobic bacteria.
Brook I
J Orthop Sci; 2008 Mar; 13(2):160-9. PubMed ID: 18392922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
